Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)
批准号:
10187395
负责人:
CHARLESNIKA T EVANS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-10-01 至 2025-09-30
关键词:
2019-nCoVAddressAdoptionAdvisory CommitteesAntibiotic ResistanceAntibioticsAntimicrobial ResistanceAreaBehaviorCOVID-19COVID-19 pandemicCaringCenters for Disease Control and Prevention (U.S.)Cessation of lifeCharacteristicsClinicalCollaborationsCommunicable DiseasesCountryDataData CollectionData SetDevelopmentDevelopment PlansDiseaseDisease ResistanceDisinfectionEducationEmerging Communicable DiseasesEngineeringEnsureEvaluationEventEvidence based practiceExhibitsFeedbackFocus GroupsFutureGenerationsGoalsGuidelinesHealthHealth care facilityHealthcareHealthcare SystemsImProvIndividualInfectionInfection ControlInfection preventionInfrastructureIntegrated Health Care SystemsInterventionInterviewInvestmentsLeadershipMentorsMethodsMissionModelingModernizationMorbidity - disease rateOrganismOutcomePatient CarePerformancePhasePoliciesPositioning AttributePreventionProcessProviderPublic HealthQuality of CareRecording of previous eventsRecordsReportingResearchResearch PersonnelResistanceSafetyScientistSecondary toSeriesServicesSiteSurveysSystemTestingTimeTouch sensationTrainingTreatment FailureUncertaintyUnited StatesVeteransWorkantimicrobialcarbapenem resistancecareercareer developmentcostdesigndrug resistant pathogeneffectiveness evaluationemerging pathogenexperiencehealth care qualityhealth care settingshealthcare-associated infectionsimplementation scienceimplementation strategyimprovedinnovationinterestmortalitymulti-drug resistant pathogennovelpandemic diseasepathogenpatient safetypreventprogramsresilienceresponseroutine caresuccesstheoriestransmission processultravioletuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background: Under-investments in antimicrobial discovery, antimicrobial stewardship, and infection control
have reached crisis proportions. While these under-investments have been laid bare by SARS-CoV-2, antimi-
crobial-resistant infections—a more silent killer—are accelerating with three million illnesses, 48,000 deaths
and $35 billion in excess costs annually in the US, secondary to treatment failure and associated higher
morbidity and mortality. The ongoing pandemic of COVID-19, the disease caused by SARS-CoV-2, has also
revealed much about the limits of our public health infrastructure and the need to rapidly engage partners, dis-
seminate best practices, and adapt to changing conditions during times of widespread uncertainty. Our
national, integrated healthcare system for Veterans offers unique opportunities to significantly alter the course
of events and improve the outlook for our future through novel implementation and quality improvement efforts.
Objectives: The goal of this QUERI program is to continue the successes of its predecessor by addressing the
growing concern of antimicrobial resistance and other emerging infectious threats through strategies that train,
communicate, and coordinate front-line staff, operational leaders, and field experts. In doing so, we will
address the priority goals of our VA operational partners, increase the impact of VA research findings through
bi-directional partnerships and rigorous evaluation, and promote VA as a high reliability organization through
innovative implementation science. Three projects designed to implement key evidence-based practices in the
areas of infection prevention, biosurveillance, and antimicrobial stewardship will target the behaviors and
processes that facilitate the spread of antibiotic-resistant and other emerging pathogens, including (1) improv-
ing patient safety through overcoming barriers to Ultraviolet-C (UVC) no-touch room disinfection; (2) improving
implementation of strategies to prevent the spread of carbapenem-resistant organisms (CROs); and (3)
estimating the impact of two different electronic audit and feedback strategies on antimicrobial prescribing
practices. These efforts will be supplemented with time-sensitive rapid response projects guided by our
operational partners to assist their work with front-line providers across the country. We will also train a new
generation of VA implementation scientists through our mentoring core, led by investigators committed to
developing junior implementation researchers committed to careers improving the quality, safety, and value of
Veteran health care.
Methods: The program will employ complementary implementation strategies and theories guided by an
Implementation Core consisting of a team of notable VA implementation scientists with proven track records in
designing and executing programs to control antimicrobial resistance and prevent the spread of pathogens. We
will follow the principles of High Reliability Organizations to deliver reliable performance, consistent safety, and
exceptional quality, using approaches that are aligned with the three phases of the QUERI Implementation
Roadmap (pre-implementation, implementation, and sustainment). Specific implementation strategies will
include blended (internal and external) facilitation, audit and feedback, and provider and staff education and
activation. Work system barriers and facilitators will be assessed using the Systems Engineering Initiative for
Patient Safety (SEIPS) model, which will help identify factors that influence the processes of care and inform
data collection methods that will include the use of national VA datasets, direct observation, and primary data
(i.e., surveys, interviews, and focus groups). Finally, our Mentoring Core will utilize the Matrix Mentoring Model
as a framework to provide each trainee with a team of mentors, each contributing unique expertise. Trainees
will follow a personalized career development plan, and will have opportunities to participate in rapid response
projects to gain experience interfacing with VA operational partners.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team (VAST)
-
批准号:10672768
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team (VAST)
-
批准号:10620614
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team (VAST)
-
批准号:10312278
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
HSR&D Research Career Scientist Award
-
批准号:10535424
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
HSR&D Research Career Scientist Award
-
批准号:10005574
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Effectiveness of Treatment and Outcomes for Veterans Infected with Resistant Gram-negative Organisms.
-
批准号:10186505
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Effectiveness of Treatment and Outcomes for Veterans Infected with Resistant Gram-negative Organisms.
-
批准号:9502631
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Effectiveness of Treatment and Outcomes for Veterans Infected with Resistant Gram-negative Organisms.
-
批准号:9695865
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)
-
批准号:9205309
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Combating Antimicrobial Resistance through Rapid Implementation of Available Guidelines and Evidence (CARRIAGE)
-
批准号:10200821
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Antibiotic prescribing practice in the spinal cord injury system of care
-
批准号:8846420
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Burden and Outcomes of Resistant Gram-negative Organisms in Veterans with SCI/D
-
批准号:8818457
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
Burden and Outcomes of Resistant Gram-negative Organisms in Veterans with SCI/D
-
批准号:9040024
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
C. Difficile Outcomes and Effectiveness of Treatment Strategies in SCI
-
批准号:8082154
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
C. Difficile Outcomes and Effectiveness of Treatment Strategies in SCI
-
批准号:8292933
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:CHARLESNIKA T EVANS
-
依托单位:
海外基金